Clinical Laserthermia Systems
4.85 SEK -5.72%1 investor is following this company
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CLS B
Daily low / high price
4.83 / 5.144
SEK
Market cap
67.57M SEK
Turnover
212.78K SEK
Volume
43K
Financial calendar
Extraordinary general meeting
21.10.2024
Interim report
15.11.2024
Annual report
21.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 6.8 % | 6.8 % |
Nordnet Pensionsförsäkring | 6.7 % | 6.7 % |
Handelsbanken Liv Försäkringsaktiebolag | 5.6 % | 5.6 % |
Ålandsbanken | 3.9 % | 3.8 % |
Arne Håkanson | 2.6 % | 2.6 % |
Deutsche Bank AG | 2.5 % | 2.5 % |
Anders Berthag | 1.3 % | 1.3 % |
Rickard Danielsson | 1.1 % | 1.0 % |
Harry Sjöblom | 1.0 % | 1.0 % |
Sven Lennartsson | 1.0 % | 1.0 % |
ShowingAll content types
CLS announces proposal for changes to the Board of Directors
Redeye: CLS Q2 - A quarter in line with our expectations
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools